Inventor · disambiguated record
Marina Roell
Also filed as: ROELL MARINA · ROELL MARINA K
18 granted patents·8 pending applications·202 citations·filing 2006–2025
95Inventor score
Top patents by PatentIndex Score
26 records- 0197US7531166B2IL-1β binding antibodies and fragments thereofXOMA TECHNOLOGY LTD·Filed 2006·Granted May 12, 2009·49 cites·10 claims
- 0296US7744865B2IL1-β Binding antibodies and fragments thereofXOMA TECHNOLOGY LTD·Filed 2009·Granted Jun 29, 2010·23 cites·10 claims
- 0396US7582742B2Method of treating or preventing an IL-1 related disease or conditionXOMA TECHNOLOGY LTD·Filed 2008·Granted Sep 1, 2009·23 cites·12 claims
- 0495US7829093B2Method of treating an IL-1 related autoimmune disease or conditionXOMA TECHNOLOGY LTD·Filed 2009·Granted Nov 9, 2010·21 cites·6 claims
- 0595US7695717B2Method of treating an IL-1 related inflammatory disease or conditionXOMA TECHNOLOGY LTD·Filed 2008·Granted Apr 13, 2010·21 cites·22 claims
- 0693US7829094B2Method of treating an IL-1 related cancerXOMA TECHNOLOGY LTD·Filed 2009·Granted Nov 9, 2010·13 cites·12 claims
- 0793US7744866B2IL-1β binding antibodies and binding fragments thereofXOMA TECHNOLOGY LTD·Filed 2009·Granted Jun 29, 2010·12 cites·10 claims
- 0892US7943121B2IL-1β binding antibodies and fragments thereofXOMA TECHNOLOGY LTD·Filed 2009·Granted May 17, 2011·11 cites·10 claims
- 0990US7988968B2Method of treating an IL-1 related coronary conditionXOMA TECHNOLOGY LTD·Filed 2009·Granted Aug 2, 2011·7 cites·12 claims
- 1088US9206252B2Pharmaceutical compositions comprising IL-1B binding antibodies and fragments thereofXOMA TECHNOLOGY LTD·Filed 2013·Granted Dec 8, 2015·5 cites·13 claims
- 1188US8377442B2Method of treating inflammatory eye disease with IL-1β binding antibodiesXOMA TECHNOLOGY LTD·Filed 2011·Granted Feb 19, 2013·6 cites·10 claims
- 1281US8278421B2Human antibodies specific for gastrin materials and methodsMASAT LINDA·Filed 2006·Granted Oct 2, 2012·6 cites·23 claims
- 1375US10858428B2Antibodies that bind interleukin-2 and uses thereofXOMA US LLC·Filed 2017·Granted Dec 8, 2020·2 cites·31 claims
- 1474US2024287204A1Anti-mertk antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 1571US9885711B2Screening methodsWHITE MARK L·Filed 2010·Granted Feb 6, 2018·3 cites·77 claims
- 1662US12234285B2Antibodies that bind interleukin-2 and uses thereofXOMA US LLC·Filed 2020·Granted Feb 25, 2025·0 cites·14 claims
- 1762US11897968B2Anti-MerTK antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Feb 13, 2024·0 cites·23 claims
- 1862US2024254227A1Anti-CD300LB Antibodies and Methods of Use ThereofALECTOR LLC·Filed 2024·Application pending·0 cites
- 1961US8546307B2Triple tag sequence and methods of use thereofRONDON ISAAC·Filed 2009·Granted Oct 1, 2013·0 cites·1 claims
- 2061US2024279341A1Bispecific anti-mertk and anti-pdl1 antibodies and methods of use thereofALECTOR LLC·Filed 2022·Application pending·0 cites
- 2161US2024279358A1Monovalent anti-mertk antibodies and methods of use thereofALECTOR LLC·Filed 2022·Application pending·0 cites
- 2260US2025333523A1Anti-IL18 Binding Protein Antibodies and Methods of Use ThereofALECTOR LLC·Filed 2025·Application pending·0 cites
- 2351US8546308B2Triple tag sequences and methods of use thereofRONDON ISAAC·Filed 2011·Granted Oct 1, 2013·0 cites·8 claims
- 2450US2024294650A1Anti-mertk antibodies and methods of use thereofALECTOR LLC·Filed 2021·Application pending·0 cites
- 2549US2018231545A1Screening MethodsXOMA TECHNOLOGY LTD·Filed 2018·Application pending·0 cites
- 2644US2025270343A1Anti-gpnmb antibodies and methods of use thereofALECTOR LLC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →